These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9624611)

  • 1. Epstein-Barr virus expression within keratinizing nasopharyngeal carcinoma.
    Zhang JX; Chen HL; Zong YS; Chan KH; Nicholls J; Middeldorp JM; Sham JS; Griffin BE; Ng MH
    J Med Virol; 1998 Jul; 55(3):227-33. PubMed ID: 9624611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus is detected in undifferentiated nasopharyngeal carcinoma but not in lymphoepithelioma-like carcinoma of the urinary bladder.
    Gulley ML; Amin MB; Nicholls JM; Banks PM; Ayala AG; Srigley JR; Eagan PA; Ro JY
    Hum Pathol; 1995 Nov; 26(11):1207-14. PubMed ID: 7590694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia.
    Pathmanathan R; Prasad U; Chandrika G; Sadler R; Flynn K; Raab-Traub N
    Am J Pathol; 1995 Jun; 146(6):1355-67. PubMed ID: 7778675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Epstein-Barr virus in nasopharyngeal carcinoma by in situ hybridization and polymerase chain reaction.
    Murono S; Yoshizaki T; Tanaka S; Takeshita H; Park CS; Furukawa M
    Laryngoscope; 1997 Apr; 107(4):523-6. PubMed ID: 9111384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Latency of Epstein-Barr virus and its relationship to nasopharyngeal carcinomas].
    You S; Yao K; Cao Y
    Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):23-6. PubMed ID: 8732106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
    Chiang AK; Tao Q; Srivastava G; Ho FC
    Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of latent Epstein-Barr virus (EBV) DNA in paraffin sections of nasopharyngeal carcinomas expressing no EBV-encoded small RNAs using in situ PCR.
    Takeuchi H; Kobayashi R; Hasegawa M; Hirai K
    Arch Virol; 1997; 142(9):1743-56. PubMed ID: 9672634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma.
    Pathmanathan R; Prasad U; Sadler R; Flynn K; Raab-Traub N
    N Engl J Med; 1995 Sep; 333(11):693-8. PubMed ID: 7637746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of Epstein-Barr virus genomes in nasopharyngeal carcinoma].
    Furukawa M; Murono S; Nakagawa S; Takeshita H; Yoshizaki T
    Nihon Rinsho; 1997 Feb; 55(2):346-9. PubMed ID: 9046821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma.
    Murono S; Yoshizaki T; Park CS; Furukawa M
    Histopathology; 1999 May; 34(5):432-8. PubMed ID: 10231418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma.
    Heussinger N; Büttner M; Ott G; Brachtel E; Pilch BZ; Kremmer E; Niedobitek G
    J Pathol; 2004 Jun; 203(2):696-9. PubMed ID: 15141385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.
    Sugiura M; Imai S; Tokunaga M; Koizumi S; Uchizawa M; Okamoto K; Osato T
    Br J Cancer; 1996 Aug; 74(4):625-31. PubMed ID: 8761381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody.
    Brousset P; Butet V; Chittal S; Selves J; Delsol G
    Lab Invest; 1992 Oct; 67(4):457-64. PubMed ID: 1331609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma.
    Chao TY; Chow KC; Chang JY; Wang CC; Tsao TY; Harn HJ; Chi KH
    Cancer; 1996 Jul; 78(1):24-9. PubMed ID: 8646721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma.
    Niedobitek G; Agathanggelou A; Nicholls JM
    Semin Cancer Biol; 1996 Aug; 7(4):165-74. PubMed ID: 8946600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus DNA in nasopharyngeal carcinoma in Thai patients at Ramathibodi Hospital, Bangkok.
    Niemhom S; Maeda S; Raksakait K; Petchclai B
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():325-8. PubMed ID: 8629135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas.
    Niedobitek G; Young LS; Sam CK; Brooks L; Prasad U; Rickinson AB
    Am J Pathol; 1992 Apr; 140(4):879-87. PubMed ID: 1314028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBER in situ hybridization differentiates carcinomas originating from the sinonasal region and the nasopharynx.
    Hwang TZ; Jin YT; Tsai ST
    Anticancer Res; 1998; 18(6B):4581-4. PubMed ID: 9891522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological study, immunohistochemistry and in situ hybridization studies of nasopharyngeal carcinomas: a Tunisian report.
    Hila L; Farah F; Ayari H; Ferjaoui M; Dehria W; Ben Jilani S
    Pathol Biol (Paris); 2009 Jul; 57(5):427-9. PubMed ID: 18835109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase.
    Niedobitek G; Young LS; Lau R; Brooks L; Greenspan D; Greenspan JS; Rickinson AB
    J Gen Virol; 1991 Dec; 72 ( Pt 12)():3035-46. PubMed ID: 1662695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.